<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38932339</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>03</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Impact of Circulating Anti-Spike Protein Antibody Levels on Multi-Organ Long COVID Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">610</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12060610</ELocationID><Abstract><AbstractText>Patients with long COVID syndrome present with various symptoms affecting multiple organs. Vaccination before or after SARS-CoV-2 infection appears to reduce the incidence of long COVID or at least limit symptom deterioration. However, the impact of vaccination on the severity and extent of multi-organ long COVID symptoms and the relationship between the circulating anti-spike protein antibody levels and the severity and extent of multi-organ symptoms are unclear. This prospective cohort study included 198 patients with previous PCR-verified SARS-CoV-2 infection who met the criteria for long COVID syndrome. Patients were divided into vaccinated (<i>n</i> = 138, 69.7%) or unvaccinated (<i>n</i> = 60, 30.3%) groups. Anti-spike protein antibody levels were determined at initial clinical presentation and compared between the groups. Long COVID symptoms were quantified on the basis of the number of affected organs: Class I (mild) with symptoms in three organs, Class II (moderate) with symptoms in four to five organs, and Class III (severe) with symptoms in six or more organ systems. Associations between time to infection and vaccination with anti-spike protein antibody levels were assessed. The anti-spike protein antibody levels were 1925 &#xb1; 938 vs. 481 &#xb1; 768 BAU/mL (<i>p</i> &lt; 0.001) in the vaccinated vs. unvaccinated patients. The circulating anti-spike antibody cutoff of 665.5 BAU/mL allowed us to differentiate the vaccinated from the unvaccinated patients. Vaccinated patients had fewer class II and class III multi-organ symptoms (Class II 39.9% vs. 45.0%; Class III 10.1% vs. 23.3%, <i>p</i>-value 0.014). Anti-spike antibody level correlated negatively with multi-organ symptom classes (<i>p</i> = 0.016; 95% CI -1.229 to -0.126). Anti-spike antibody levels in unvaccinated patients declined markedly with time, in contrast to the persistence of high anti-spike antibody levels in the vaccinated patients. Multi-organ symptoms were lower in vaccinated long-COVID patients, especially in those with higher anti-spike antibody levels (&#x2265;665.5 BAU/mL). Classifying the symptoms on the basis of the number of affected organs enables a more objective symptom quantification.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hamzaraj</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2505-8554</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Emilie</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3064-1277</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasimbegovic</LastName><ForeName>Ena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poschenreiter</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vavrikova</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukovic</LastName><ForeName>Dominika</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8040-8086</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kastrati</LastName><ForeName>Lisbona</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergler-Klein</LastName><ForeName>Jutta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gy&#xf6;ngy&#xf6;si</LastName><ForeName>Mariann</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7083-2107</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KLI 1064-B</GrantID><Agency>FWF Austrian Science Fund</Agency><Country/></Grant><Grant><GrantID>21176</GrantID><Agency>Medical Scientific Fund of the Mayor of the City of Vienna</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anti-spike protein antibody</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">multiorgan symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest related to this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38932339</ArticleId><ArticleId IdType="pmc">PMC11209431</ArticleId><ArticleId IdType="doi">10.3390/vaccines12060610</ArticleId><ArticleId IdType="pii">vaccines12060610</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vos T., Hanson S.W., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., et al. Estimated Global Proportions of Individuals with Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615. doi: 10.1001/JAMA.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Cancela-Cilleruelo I., Rodr&#xed;guez-Jim&#xe9;nez J., Fuensalida-Novo S., Mart&#xed;n-Guerrero J.D., Pellicer-Valero O.J., de-la-Llave-Rinc&#xf3;n A.I. Trajectory of Post-COVID Self-Reported Fatigue and Dyspnoea in Individuals Who Had Been Hospitalized by COVID-19: The LONG-COVID-EXP Multicenter Study. Biomedicines. 2023;11:1863. doi: 10.3390/BIOMEDICINES11071863.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOMEDICINES11071863</ArticleId><ArticleId IdType="pmc">PMC10376654</ArticleId><ArticleId IdType="pubmed">37509504</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long Covid&#x2014;Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/BMJ.N1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.N1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Brady M., Hishmeh L., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: A prospective, community-based study. BMJ Open. 2021;11:3048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Do Vaccines Protect against Long COVID? What the Data Say. Nature. 2021;599:546&#x2013;548. doi: 10.1038/D41586-021-03495-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/D41586-021-03495-2</ArticleId><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective Effect of COVID-19 Vaccination against Long COVID Syndrome: A Systematic Review and Meta-Analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/J.VACCINE.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.VACCINE.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E., Levi R., Sarti R., Pozzi C., Mollura M., Mantovani A., Rescigno M. Association between BNT162b2 Vaccination and Long COVID after Infections Not Requiring Hospitalization in Health Care Workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/JAMA.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after Breakthrough SARS-CoV-2 Infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of Long Covid Symptoms after Covid-19 Vaccination: Community Based Cohort Study. BMJ. 2022;377:e069676. doi: 10.1136/BMJ-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain W.D., Sherwood O., Banerjee A., Van der Togt V., Hishmeh L., Rossman J. The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID. Vaccines. 2022;10:652. doi: 10.3390/VACCINES10050652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Varnai R., Molnar T., Zavori L., T&#x151;k&#xe9;s-F&#xfc;zesi M., Illes Z., Kanizsai A., Csecsei P. Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms. Vaccines. 2022;10:165. doi: 10.3390/VACCINES10020165/S1.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES10020165/S1</ArticleId><ArticleId IdType="pmc">PMC8924883</ArticleId><ArticleId IdType="pubmed">35214624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., Han A.X., Boyd A., van Willigen H.D.G., Verveen A., Lebbink R., van der Straten K., Kootstra N., van Gils M.J., Russell C., et al. The Effect of SARS-CoV-2 Vaccination on Post-Acute Sequelae of COVID-19 (PASC): A Prospective Cohort Study. Vaccine. 2022;40:4424&#x2013;4431. doi: 10.1016/J.VACCINE.2022.05.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.VACCINE.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M., Lukovic D., Mester-Tonczar J., Zlabinger K., Einzinger P., Spannbauer A., Schweiger V., Schefberger K., Samaha E., Bergler-Klein J., et al. Effect of Monovalent COVID-19 Vaccines on Viral Interference between SARS-CoV-2 and Several DNA Viruses in Patients with Long-COVID Syndrome. NPJ Vaccines. 2023;8:145. doi: 10.1038/S41541-023-00739-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41541-023-00739-2</ArticleId><ArticleId IdType="pmc">PMC10541897</ArticleId><ArticleId IdType="pubmed">37773184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes L.D., Ingram J., Sculthorpe N.F. More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review. Front. Med. 2021;8:750378. doi: 10.3389/FMED.2021.750378/BIBTEX.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMED.2021.750378/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Nicholson T., Akrami A., Apfelbacher C., Chen J., De Groote W., Diaz J.V., Gorst S.L., Harman N., Kokorina A., et al. A Core Outcome Set for Post-COVID-19 Condition in Adults for Use in Clinical Practice and Research: An International Delphi Consensus Study. Lancet Respir. Med. 2022;10:715&#x2013;724. doi: 10.1016/S2213-2600(22)00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Parotto M., Gy&#xf6;ngy&#xf6;si M., Howe K., Myatra S.N., Ranzani O., Shankar-Hari M., Herridge M.S. Post-Acute Sequelae of COVID-19: Understanding and Addressing the Burden of Multisystem Manifestations. Lancet Respir. Med. 2023;11:739&#x2013;754. doi: 10.1016/S2213-2600(23)00239-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00239-4</ArticleId><ArticleId IdType="pubmed">37475125</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int. J. Env. Res. Public Health. 2022;19:12422. doi: 10.3390/IJERPH191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJERPH191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 Vaccination on the Risk of Developing Long-COVID and on Existing Long-COVID Symptoms: A Systematic Review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Desimmie B.A., Raru Y.Y., Awadh H.M., He P., Teka S., Willenburg K.S. Insights into SARS-CoV-2 Persistence and Its Relevance. Viruses. 2021;13:1025. doi: 10.3390/V13061025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/V13061025</ArticleId><ArticleId IdType="pmc">PMC8228265</ArticleId><ArticleId IdType="pubmed">34072390</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Pijnenburg L., Chatelus E., Arnaud L., Gottenberg J.E., Sibilia J., Felten R. Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study. Vaccines. 2021;10:46. doi: 10.3390/VACCINES10010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES10010046</ArticleId><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long Covid in Adults Discharged from UK Hospitals after COVID-19: A Prospective, Multicentre Cohort Study Using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health Eur. 2021;8:100186. doi: 10.1016/J.LANEPE.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.LANEPE.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., Ballouz T., Menges D., Hasler S., Adamo S., Raeber M.E., B&#xe4;chli E., Rudiger A., et al. Immunoglobulin Signature Predicts Risk of Post-Acute COVID-19 Syndrome. Nat. Commun. 2022;13:1&#x2013;12. doi: 10.1038/S41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Tymoszuk P., Sahanic S., Boehm A., Pizzini A., Luger A., Schwabl C., Nairz M., Grubwieser P., Kurz K., et al. Investigating Phenotypes of Pulmonary COVID-19 Recovery: A Longitudinal Observational Prospective Multicenter Trial. Elife. 2022;11:e72500. doi: 10.7554/ELIFE.72500.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/ELIFE.72500</ArticleId><ArticleId IdType="pmc">PMC8896831</ArticleId><ArticleId IdType="pubmed">35131031</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T., Varnai R., Schranz D., Zavori L., Peterfi Z., Sipos D., T&#x151;k&#xe9;s-f&#xfc;zesi M., Illes Z., Buki A., Csecsei P. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms. J. Clin. Med. 2021;10:4337. doi: 10.3390/JCM10194337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM10194337</ArticleId><ArticleId IdType="pmc">PMC8509483</ArticleId><ArticleId IdType="pubmed">34640355</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a Prospective Cohort of Home-Isolated Patients. Nat. Med. 2021;27:1607. doi: 10.1038/S41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>